Concepedia

Darko Skegro

DS

7

Publications

246

Citations

7

H-Index

2007

Active since

Affiliations

University of Basel(Current)

Glenmark Pharmaceuticals (Switzerland)

Darko Skegro is an author at University of Basel specializing in natural sciences, biochemistry, and biocatalysis.

ORCID

Top concepts

Publications per year

2007–2018

7

Publications

7

Conformational dynamics of helix 8 in the GPCR rhodopsin controls arrestin activation in the desensitization process

Kristina Kirchberg, Tai‐Yang Kim, Martina Möller et al. · Proceedings of the National Academy of Sciences · 2011 · 92 citations · Full text

Immunoglobulin domain interface exchange as a platform technology for the generation of Fc heterodimers and bispecific antibodies

Darko Skegro, Cian Stutz, Romain Ollier et al. · Journal of Biological Chemistry · 2017 · 46 citations · Full text

Mechanistic Insights of an Immunological Adverse Event Induced by an Anti-KIT Antibody Drug Conjugate and Mitigation Strategies

Lawrence L’Italien, Olivia Orozco, Tinya J. Abrams et al. · Clinical Cancer Research · 2018 · 28 citations · Full text

BEAT® the bispecific challenge: a novel and efficient platform for the expression of bispecific IgGs

Pierre Moretti, Darko Skegro, Romain Ollier et al. · BMC Proceedings · 2013 · 27 citations · Full text

A Rationally Designed Monomeric Variant of Anthranilate Phosphoribosyltransferase from Sulfolobus solfataricus is as Active as the Dimeric Wild-type Enzyme but Less Thermostable

Thomas Schwab, Darko Skegro, Olga Mayans et al. · Journal of Molecular Biology · 2007 · 26 citations

, , +11

Rows per page

1–5 of 7